Skip to main content

Table 1 A comparison of serum biomarkers levels in both patient groups

From: Cardio embolic stroke and blood biomarkers: diagnosis and predictors of short-term outcome

Blood biomarkers Group Ι (CES) Group ΙΙ (non-CES) Test of significance(t test) P
BNP
 Mean ± SD (pg/ml) range 134.6 ± 93.3 (100–420) 68.33 ± 12.69 (50–95) − 5.046 < 0.001**
CK-MB
 Mean ± SD (ng/ml) range 1.61 ± 0.59 (0.5–2.6) 0.76 ± 0.19 (0.5–1) 9.49 < 0.001**
d-Dimer
 Mean ± SD (ng/ml) range 613.19 ± 275.02 (250–1090) 277.92 ± 80.16 (100–500) 8.109 < 0.001**
CRP
 Mean ± SD (mg/l) range 28.72 ± 26.31 (5–100) 34.91 ± 27.39 (5–109) −1.129 0.262
G/A ratio
 Mean ± SD range 0.73 ± 0.04 (0.63–0.79) 0.71 ± 0.06 (0.62–0.79) 1.369 0.175
  1. CES cardio-embolic stroke, non CES non-cardio-embolic stroke, BNP brain natriuretic peptide, CK-MB creatine–kinase, CRP C-reactive protein, G/A globulin/albumin
  2. **Statistically highly significant